FDA Investigates Safety Concerns in Sarepta's Gene Therapy Trials
TL;DR Summary
Two boys died after receiving gene therapy, but one family remains hopeful as Andrew Revell, who participated in a clinical trial for a muscle-destroying disease, struggles to see if the treatment has helped him, despite his physical challenges.
- Two boys died after a gene therapy. This family won’t give up hope. washingtonpost.com
- FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy Reuters
- A mother’s perspective on Sarepta’s gene therapy halt statnews.com
- 'We will crack gene therapy': Elevidys fallout doesn't dent Roche's hopes for modality Fierce Biotech
- FDA weighs new study requirements for Sarepta to confirm safety of gene therapy Elevidys: report Fierce Pharma
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
0 min
vs 1 min read
Condensed
41%
64 → 38 words
Want the full story? Read the original article
Read on washingtonpost.com